TCI GENE INC.
大江基因醫學股份有限公司
Leave your email for change alerts (optional)
2011Founded
NT$265MPaid-in capital
0Plants
3Certifications
5Patents
NT$100–500MRevenue band
- Unified Business No.
- 53357669
- Industry
- Tobacco Manufacturing (1,186)
- Listing
- Emerging stock (TPEx) (359) 6879
- Founded
- 2011-07-13
- Paid-in capital
- NT$ 264,585,200
- Phone
- 02-26581218
- Website
- https://www.tci-gene.com/zh-TW
- Exporter
- Yes — registered with the Trade Administration
- Annual revenue band
- NT$100–500M
- Ownership
- Group subsidiary / corporate-held · TCI CO., LTD.、QISDA CORPORATION
- North American market
- FDA medical device registration
- Representative tenure
- In office since 2015-09 (11 yrs); last handover 2015-09
- Growth & profitability
- Revenue 2026-09 YoY -23.3%, year-to-date -13.3%
Gross margin 57%, operating margin 14.6%, net margin 11.1% (2026-Q2 YTD)
Certifications 3
- Medical device license (Class I) (1,430)Official registry Valid until 2025-07-21 · Taiwan Food and Drug Administration (TFDA)
- Medical device license (Class I) (1,430)Official registry Valid until 2025-04-09 · Taiwan Food and Drug Administration (TFDA)
- Medical device license (Class I) (1,430)Official registry Valid until 2021-04-06 · Taiwan Food and Drug Administration (TFDA)
Patents 5
- 2025 Target molecule-cell complex and preparation method thereof
- 2023 Device and method for preparing sample
- 2022 Automated nucleic acid detection system and automated nucleic acid dispensing system
North American market evidence 1
- FDA medical device registration 3017305295 2020-06-11
Device, Microtiter Diluting/Dispensing
Similar companies 10
- Anti-Microbial Savior BioteQ Co., Ltd. Emerging stock (TPEx) < NT$20M
Shared: Medical device license (Class I), Other professional, scientific & technical services n.e.c. - King House CO., Ltd. Listed (TPEx) NT$1–5B
Shared: Other professional, scientific & technical services n.e.c., Other management consulting n.e.c. - LIBO PHARMA CORP. Emerging stock (TPEx) NT$0.5–1B estimated
Shared: Medical biological products manufacturing - BoYen Therapeutics, INC. Emerging stock (TPEx) NT$0.5–1B estimated
Shared: Medical biological products manufacturing - SHINE-ON BIOMEDICAL CO., LTD. Emerging stock (TPEx) NT$20–100M
Shared: Other professional, scientific & technical services n.e.c., Medical biological products manufacturing - LEVEL BIOTECHNOLOGY INC. Listed (TPEx) NT$0.5–1B
Shared: Medical device license (Class I), Medical biological products manufacturing - MICRO ELECTRICITY CO. LTD. Public company (unlisted) NT$100–500M
Shared: Other professional, scientific & technical services n.e.c., Other management consulting n.e.c. - ZI JIN TANG CO., LTD. Public company (unlisted) < NT$20M
Shared: Medical device license (Class I), Other management consulting n.e.c., Other food wholesale n.e.c. - PANLABS BIOLOGICS INC. · New Taipei City NT$0.5–1B estimated
Shared: Other professional, scientific & technical services n.e.c., Other management consulting n.e.c., Medical biological products manufacturing - ORIGINAL BIOMEDICALS CO., LTD. Emerging stock (TPEx) NT$100–500M estimated
Shared: Other professional, scientific & technical services n.e.c., Other management consulting n.e.c.